Los Angeles Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Los Angeles Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,973	Closed	-$270K	–	1575
2020 Q2	$270K	Sell	5,973 -150	-2%	-$6.72K	﹤0.01%	1317
2020 Q1	$236K	Buy	6,123 +460	+8%	+$21.2K	﹤0.01%	1135
2019 Q4	$262K	Sell	5,663 -1,890	-25%	-$81.8K	﹤0.01%	1156
2019 Q3	$308K	Hold	7,553	–	–	﹤0.01%	1118
2019 Q2	$364K	Buy	7,553 +3,160	+72%	+$166K	﹤0.01%	1129
2019 Q1	$275K	Hold	4,393	–	–	﹤0.01%	1218
2018 Q4	$262K	Buy	+4,393	New	+$264K	﹤0.01%	1140
2018 Q1	–	Sell	-24,653	Closed	-$737K	–	1471
2017 Q4	$737K	Buy	24,653 +17,633	+251%	+$511K	﹤0.01%	941
2017 Q3	$232K	Buy	+7,020	New	+$243K	﹤0.01%	1214

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Los Angeles Capital Management's BEAT Position: Q3 2020 in Review

Los Angeles Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 5,973 shares — an estimated $270K sold.

Los Angeles Capital Management first reported a position in BEAT in Q3 2017 and held it in 9 quarters. The position peaked at $737K in Q4 2017. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

Los Angeles Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
Los Angeles Capital Management sold 5,973 BioTelemetry, Inc. shares in Q3 2020, an estimated $270K.
Los Angeles Capital Management first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 9 quarters.
Los Angeles Capital Management's BioTelemetry, Inc. position peaked at $737K in Q4 2017.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Los Angeles Capital Management's 13F filing for Q3 2020, filed 2 Nov 2020.